Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer

被引：0
作者：
V Abkevich
K M Timms
B T Hennessy
J Potter
M S Carey
L A Meyer
K Smith-McCune
R Broaddus
K H Lu
J Chen
T V Tran
D Williams
D Iliev
S Jammulapati
L M FitzGerald
T Krivak
J A DeLoia
A Gutin
G B Mills
J S Lanchbury
机构：
[1] Myriad Genetics Inc.,Department of Medical Oncology
[2] Beaumont Hospital and Royal College of Surgeons in Ireland (RCSI),Department of Obstetrics and Gynecology
[3] University of British Colombia,Department of Obstetrics
[4] Gynecology and Reproductive Sciences,Department of Obstetrics
[5] The University of Texas Medical School,Department of Pathology
[6] Gynecology,Department of Gynecologic Oncology and Reproductive Medicine
[7] and Reproductive Sciences,Department of Obstetrics
[8] University of California San Francisco,Department of Exercise Science
[9] The University of Texas MD Anderson Cancer Center,undefined
[10] The University of Texas MD Anderson Cancer Center,undefined
[11] Gynecology and Reproductive Sciences,undefined
[12] University of Pittsburgh School of Medicine,undefined
[13] School of Public Health and Health Services,undefined
[14] The George Washington University,undefined
来源：
British Journal of Cancer | 2012年 / 107卷
关键词：
loss of heterozygosity; homologous recombination deficiency; ovarian cancer; DNA double-strand break repair;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1776 / 1782
页数：6
相关论文
共 243 条
  • [1] Beaudet AL(1993)A suggested nomenclature for designating mutations Hum Mutat 2 245-248
  • [2] Tsui LCA(2012)Telomeric allele imbalance indicated defective DNA repair and sensitivity to DNA-damaging agents Cancer Discov 2 366-375
  • [3] Birkbak NJ(2005)Specific killing of Nature 434 913-917
  • [4] Wang ZC(2012)-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Gynecol Oncol 125 677-682
  • [5] Kim JY(2011) mutations and expression: response to platinum chemotherapy in patients with advanced epithelial ovarian cancer Cancer Treat Rev 38 89-100
  • [6] Eklund AC(2008)Defective homologous recombination in human cancers Nature 451 1111-1115
  • [7] Li Q(2005)Resistance to therapy caused by intragenic deletion in Nature 434 917-921
  • [8] Tian R(2005)Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy MolGenMed 7 60-861
  • [9] Bowman-Colin C(2011) and Lancet Oncol 12 852-3576
  • [10] Li Y(2010) pathways and the risk of cancers other than breast or ovarian J Clin Oncol 28 3570-882
12345678910